网站综合信息 pcut.org
- 标题:
- PCUT BioPartners
- 关键字:
- PCUT ALS Lou Gehrigs Mecasermine Rinfabate Compassionate Use Treat
- 描述:
- Partnership for Compassionate Use Therapies works to make promising treatments available to sufferer
- 域名信息
- 服务器空间
- IP:184.168.221.22 同IP网站201个 详情
地址:美国 亚利桑那州斯科茨代尔市Go Daddy集团公司
- 备案信息
- 备案号:
域名流量Alexa排名
域名注册Whois信息
pcut.org
获取时间: 2014年10月07日 03:37:11
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS
网站头文件(HTTP Header)
HTTP/1.1 301 永久重定向 缓存控制:max-age=900 类型:text/html 目标网址:http://www.pcutbio.com 服务器:Microsoft-IIS/7.5 ASP.NET版本:4.0.30319 语言环境:ASP.NET 访问时间:2014年10月21日 22:58:58 文件大小:0 文件时间(秒):1 连接:keep-alive HTTP/1.1 301 永久重定向 访问时间:2014年10月21日 22:58:58 X-Pingback: http://pcutbio.com/xmlrpc.php 过期时间:1981年11月19日 16:52:00 缓存控制:no-store, 不缓存,必须更新, post-check=0, pre-check=0 其他指令:不缓存 设置Cookie:PHPSESSID=ocfua51gpaot3a919qk8fhrk13; path=/ 目标网址:http://pcutbio.com/ 文件大小:0 Keep-Alive: timeout=5, max=100 连接:Keep-Alive 类型:text/html; charset=UTF-8 HTTP/1.1 200 OK 访问时间:2014年10月21日 22:58:58 X-Pingback: http://pcutbio.com/xmlrpc.php 过期时间:1981年11月19日 16:52:00 缓存控制:no-store, 不缓存,必须更新, post-check=0, pre-check=0 其他指令:不缓存 设置Cookie:PHPSESSID=n9lj32sk1gbk2dn5si1f54hta0; path=/ 动作:Accept-Encoding Content-Encoding: gzip 文件大小:3964 Keep-Alive: timeout=5, max=100 连接:Keep-Alive 类型:text/html; charset=UTF-8 网站编码:UTF-8
同IP网站(同服务器)
网站首页快照(纯文字版)
抓取时间:2014年10月21日 22:55:19
网址:http://pcut.org/
标题:PCUT BioPartners
关键字:PCUT, ALS, Lou Gehrigs, Mecasermine Rinfabate, Compassionate Use Treatment, motor neuron, neuromuscular degeneration, ne
描述:Partnership for Compassionate Use Therapies works to make promising treatments available to sufferers of terminal illnesses, particularly in cases where no other effective treatment options exist.
主体:
网址:http://pcut.org/
标题:PCUT BioPartners
关键字:PCUT, ALS, Lou Gehrigs, Mecasermine Rinfabate, Compassionate Use Treatment, motor neuron, neuromuscular degeneration, ne
描述:Partnership for Compassionate Use Therapies works to make promising treatments available to sufferers of terminal illnesses, particularly in cases where no other effective treatment options exist.
主体:
Contact Us HOMEAbout UsOur PhilosophyManagement TeamAdvisory BoardThe PlatformPipelinePartnering SystemFor Investors Unlocking Opportunity in Existing Drugs Potentially effective drugs already exist, but they’re not getting into clinical trials for the diseases where they can do the most good. We’re here to change that.read more Enabling Development through Risk Partnerships PCUT BioPartners acquires medically promising drug programs that other companies have deprioritized. Our venture partnerships allow us to clinically develop them at much lower cost.read more Low Cost, High Upside Ventures Every existing drug with potential efficacy in diseases with unmet medical need is a breakthrough opportunity. The venture platform matches these with cheap options for investors.read more PCUT BioPartners, Inc.: Clinical Development Where it’s Needed Most PCUT BioPartners is a commercial developer of early clinical stage drugs. The company licenses in products that have solid medical rationale for efficacy in any of the deadly diseases for which there is no meaningfully effective approved treatment. PCUT BioPartners is a “Venture-Biotech” structure that forms a product development team around each asset, funds the program, and spins off the LLC as a product-specific partnership (PSP). The value prospect is a reduction in front-end costs to enable greater therapy development for patients in need. Meet us April 10 - 13 Meet us March 8 - 9 Recent Event International Advocacy Focus on treatments Sample Cost Partnership 1% Prospect Sourcing from Non Profit Organizations 24% Product Development Team and Contract Research 25% Contract Manufacturing 50% PCUT BioPartners, Inc. Click here to download detailed "Cost Partnership PDF" Copyright © 2012 PCUT BioPartners, Inc. info@pcutbio.com • Phone: 415-637-4774 Powered by Warp Theme Framework
最近查询网站